Maritime Health Research and Education-NET/The International Type 2 Diabetes Mellitus and Hypertension Research Group

From Wikiversity
Jump to navigation Jump to search

International Diabetes and Hypertension Research Group[edit | edit source]

The International Diabetes and Hypertension Research Group for fishers, seafarers and other transport workers was created the 12 Jan 2022 in a Zoom conference by specialists in diabetes epidemiology, diabetology, occupational epidemiology, occupational/maritime medicine and public health from Denmark, Greenland, Spain, France, Panamá. Russia and The Filippines. [1]The aim is to provide a foundation for safe and healthy preventive strategies within the UN Global Sustainable Goals, especially Goal 3: Good health and well-being for all workers ,Goal 4: Quality education,Goal 8: Decent Work and Economic Growth and Goal 17: Partnerships to achieve the goals with the primary tasks. Millions of medical examinations are done every year for seafarers, fishers, truck drivers, loco-, bus- and taxi drivers. Most of them use the non-valid urine-sticks and no valid test for T2D, no A1c or FG. By adding biannual screening of hypertension and diabetes mellitus the target groups can be rescued from loss of workability, loss of QUALies and loss of living years. Screening for hypertension and diabetes is cost-effective and sustainable with low extra cost, possibility for no or small extra visit fee and A1C test around 20-50 USD[2] as the target group need to attend to the medical clinics for their obligatory often biannual medical examination, anyway. While the extra cost for A1c blood test, lack of laboratory access and clinical time consume might be a problem, then the strategy is to validate and replace A1C with Glukometer test[3] [4] [5] [6] [7] [8] The specific educational needs for the prevention of the diabetes type 2 and hypertension in the maritime area has never been described and a list of Workshops is planned for the next year as part of the T2D/HTN Research and Education plan 2023-2032.

T2D and HTN Research and Education plan 2023-2032[edit | edit source]

Screening program for diabetes type 2 and hypertension in seafarers’ routine medical examinations[edit | edit source]

Maritime Diabetes-type 2 Intervention study [9][edit | edit source]

Article[10][edit | edit source]

Workshops on Education and Research for the T2D/HTN prevention program[edit | edit source]

Revision of the ILO Guidelines for medical examination for seafarers[edit | edit source]

Revision of the WHO International Medical Guide for Ships[edit | edit source]

Revision of the Ships Medical Chest[edit | edit source]

Members[edit | edit source]

Learning from Interventions in non-maritime workplaces[edit | edit source]

References[edit | edit source]

  3. Chen, Huizhen, Qingtao Yao, Yang Dong, Zhimei Tang, Ruiying Li, Baochao Cai, Ruili Wang, and Qiu Chen. “The Accuracy Evaluation of Four Blood Glucose Monitoring Systems According to ISO 15197:2003 and ISO 15197:2013 Criteria.” Primary Care Diabetes 13, no. 3 (June 2019): 252–58.
  4. Chubb, S. A. Paul, Kylie Van Minnen, Wendy A. Davis, David G. Bruce, and Timothy M. E. Davis. “The Relationship between Self-Monitoring of Blood Glucose Results and Glycated Haemoglobin in Type 2 Diabetes: The Fremantle Diabetes Study.” Diabetes Research and Clinical Practice 94, no. 3 (December 2011): 371–76.
  5. Kenning, Matthes, Anselm Puchert, Sabine Berg, and Eckhard Salzsieder. “System Accuracy of the Blood Glucose Monitoring System TD4216.” Journal of Diabetes Science and Technology 14, no. 5 (March 7, 2020): 976–77.
  6. Makris, K., L. Spanou, A. Rambaouni-Antoneli, K. Koniari, I. Drakopoulos, D. Rizos, and A. Haliassos. “Relationship between Mean Blood Glucose and Glycated Haemoglobin in Type 2 Diabetic Patients.” Diabetic Medicine: A Journal of the British Diabetic Association 25, no. 2 (February 2008): 174–78.
  7. Pashintseva, L. P., V. S. Bardina, I. R. Il’iasov, B. P. Mishchenko, and M. B. Antsiferov. “[The clinical laboratory evaluation of accuracy of portable glucometers ‘Satellite Express’ and ‘Satellite Express mini’].” Klinicheskaia Laboratornaia Diagnostika, no. 11 (November 2011): 33–35.
  8. Sarwat, S., L. L. Ilag, M. A. Carey, D. S. Shrom, and R. J. Heine. “The Relationship between Self-Monitored Blood Glucose Values and Glycated Haemoglobin in Insulin-Treated Patients with Type 2 Diabetes.” Diabetic Medicine: A Journal of the British Diabetic Association 27, no. 5 (May 2010): 589–92.